Rehabilitation of Patients After Subarachnoid Hemorrhage (SAH)
The study's main objective will be to assess which effect early initiated rehabilitation has on the frequency of complications and the level of physical and cognitive functioning after aneurysmal subarachnoid hemorrhage (SAH).
To this end the following aspects will be investigated:
The frequency of complications (with special emphasis on pulmonary complications,thromboembolic events, cerebral vasospasm, unintended discontinuation of drains and lines)
- Length of stay in hospitals and socio-economic impact
- Physical and cognitive function in the early and chronic phase after SAH
- Health-related quality of life and participation in society in the chronic phase
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
|Official Title:||Effect of Early Rehabilitation in Patients With Acute Subarachnoid Hemorrhage|
- Glasgow Coma Scale (GCS) [ Time Frame: up to 10 weeks ] [ Designated as safety issue: Yes ]
- Glasgow Outcome Scale Extended (GOSE) [ Time Frame: 3-6 months and 12 months after SAH ] [ Designated as safety issue: Yes ]
- Functional Independence Measure (FIM) [ Time Frame: 3-6 months and 12 months after SAH ] [ Designated as safety issue: Yes ]
- Coma Recovery Scale (CRS) [ Time Frame: 3-6 and 12 months after SAH ] [ Designated as safety issue: Yes ]
- Disability Rating Scale (DRS) [ Time Frame: 3-6 and 12 months after SAH ] [ Designated as safety issue: Yes ]
- High Level Mobility Assessment Tool (HIMAT) [ Time Frame: 3-6 and 12 months after SAH ] [ Designated as safety issue: Yes ]
- Pain score on the Visual Analog Scale [ Time Frame: 3-6 and 12 months after SAH ] [ Designated as safety issue: Yes ]
|Study Start Date:||January 2012|
|Estimated Study Completion Date:||December 2013|
|Estimated Primary Completion Date:||December 2012 (Final data collection date for primary outcome measure)|
Active Comparator: Mobilisation of patients after SAH
Patients which were treated after SAH in 2012 will receive early multidisciplinary rehabilitation consist of individualized stimulation and mobilisation.
Mobilisation will be initiated and completed according to mobilisations guidelines which are developed and adjusted to the patients in early stage after aneurysmal SAH.
Other: Early multidisciplinary rehabilitation
Multidisciplinary rehabilitation consist of individualized stimulation and mobilisation.
The multidisciplinary team consists of a physician, a nurse, a physiotherapist, an occupational therapist and a clinical neuropsychologist.
No Intervention: Patients after SAH from 2011
Patients after SAH from 2011 which did not receive early rehabilitation and mobilisation will be followed up 3-6 annd 12 months after SAH and outcome measures compared with patients from 2011.
Oslo University Hospital (OUS) is the primary hospital for Health Region South-East regarding treatment of patients with SAH. Approximately 120 patients are referred annually. OUS,Rikshospitalet, Dept of Neurosurgery offers 24/7 service of surgical and vascular aneurysm repair performed by a dedicated vascular team.
Patients admitted in 2012 are treated in accordance to the standard institutional protocol plus an early rehabilitation model adapted to SAH, while patients admitted in 2011 who did not receive any early rehabilitation, but apart from that were treated identically, serve as a control group.
All patients admitted to the intermediate unit at OUS in 2011 and 2012 with aneurysmal SAH and repaired aneurysm will be invited to participate in this study. Examination of the patients from both 2011 and 2012 will be performed as part of routine, neurosurgical follow- up which is in the early phase at 3-6 months and in the chronic phase at least 12 months post SAH. Exclusion criteria for participation in the study: unsecured ruptured aneurysm, symptomatic aneurysm without rupture, previous SAH or brain injury, diagnosis of a neurodegenerative disorder, patients from other health regions or tourists, patients that were treated at the intensive care unit (ICU )only.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01656317
|Contact: Tanja Karic, Md||+47 firstname.lastname@example.org|
|Contact: Angelika Sorteberg, Ph.email@example.com|
|Oslo University Hospital||Recruiting|
|Oslo, Norway, 0424|
|Contact: Cecilie Røe, Professor +4722118613 firstname.lastname@example.org|
|Contact: Angelika Sorteberg, MD, Phd +4723074909 email@example.com|
|Principal Investigator:||Tanja Karic, MD||Oslo University Hospital|